MICROLAX

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania.

Active ingredients

The drug MICROLAX contains a combination of these active pharmaceutical ingredients (APIs):

1	Sorbitol solution 70% UNII 506T60A25R - SORBITOL
	Read more about Sorbitol
2	Sodium citrate UNII 1Q73Q2JULR - SODIUM CITRATE, UNSPECIFIED FORM
	Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section.
	Read more about Sodium citrate
3	Sodium lauryl sulphoacetate UNII D0Y70F2B9J - SODIUM LAURYL SULFOACETATE
	Read more about Sodium lauryl sulphoacetate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AG11	Sodium lauryl sulfoacetate, incl. combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas
Discover more medicines within A06AG11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1082629, 1082630
FI	Lääkealan turvallisuus- ja kehittämiskeskus	182382, 457734, 507813
FR	Base de données publique des médicaments	67367270, 67904304
LT	Valstybinė vaistų kontrolės tarnyba	1016297, 1016298, 1063561, 1083405, 1093380
NL	Z-Index G-Standaard	14918714
NL	Z-Index G-Standaard, PRK	1813
NZ	Medicines and Medical Devices Safety Authority	403
PL	Rejestru Produktów Leczniczych	100374039
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67166001, W67166002, W67166003, W67166004